New York, NY – February 4, 2014 – The Cardiovascular Research Foundation (CRF) today announced the appointment of Andrew F. Kraus as the foundation’s Chief Operating Officer. As COO, he will serve as the organization’s Treasurer and will oversee Finance, Information Technologies, operational and corporate digital strategies, and technology infrastructure for the CRF Skirball Research Center, CRF Clinical Trials Center and CRF Center for Education.
A successful entrepreneur and seasoned executive with over 21 years of experience in the clinical trial industry, Mr. Kraus has led business operations and driven corporate profit margins through the development and implementation of advanced technology solutions.
“We are very excited to welcome Andrew to CRF,” said Jack Lewin, MD, CRF’s Chief Executive Officer and President. “Andrew’s broad expertise and leadership in business operational efficiencies will be an invaluable asset as CRF positions itself for growth and success in the next decade in the research and development of novel technologies and therapies that will benefit people with heart disease worldwide.”
“I look forward to working with CRF’s visionary physicians who are dedicated and passionate about advancing the field of interventional cardiovascular medicine,” said Mr. Kraus. “CRF is a unique organization with a distinguished reputation for innovation and countless contributions to cardiovascular medicine and patient care.”
Mr. Kraus joins CRF from ICON, plc., one of the top five global clinical research organizations, where as Executive Vice President, Global Data Technologies, he led a team of over 250 professionals across three service groups (medical imaging, IVR/IWR/drug management, site and investigator portal) located throughout North America, Europe, and India.
Prior to ICON, Mr. Kraus founded his first company in 1998, and in 2001 was Co-Founder and served on the Board of Directors of Beacon Bioscience, a medical imaging core laboratory. During his tenure as Executive Vice President and Chief Technology Officer, ICON acquired a stake in Beacon and later completed their acquisition in 2009. He received his Bachelor’s and Master’s degrees in Bioengineering from the University of Pennsylvania with a focus on neural networks in medical image analysis.